Literature DB >> 9949798

Host genetic susceptibility to human tuberculosis.

R J Bellamy1, A V Hill.   

Abstract

Convincing evidence exists that host genes influence the outcome of infection in human tuberculosis. We are employing two complementary strategies to find the genes involved: a linkage-based, comprehensive genome screen and an association-based candidate gene study. In a genome screen of 282 markers on 92 affected sib pairs we have found evidence of co-segregation of disease with five markers, but further studies are required to replicate these results. The absence of a single strongly linked marker demonstrates that susceptibility to human tuberculosis is not controlled by a single major gene. Using a candidate gene approach investigating over 400 tuberculosis cases and 400 ethnically matched healthy controls we have found evidence that NR AMP1 and vitamin D receptor gene (VDR) polymorphisms are associated with tuberculosis. It is hoped that by identifying the genes that account for why only a minority of those exposed to tuberculosis develop disease, we will develop new insights into potential therapeutic and preventative strategies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9949798     DOI: 10.1002/0470846526.ch2

Source DB:  PubMed          Journal:  Novartis Found Symp        ISSN: 1528-2511


  9 in total

1.  Neonatal mycobacterial specific cytotoxic T-lymphocyte and cytokine profiles in response to distinct BCG vaccination strategies.

Authors:  Gregory D Hussey; Marcia L V Watkins; Elizabeth A Goddard; Sean Gottschalk; Elizabeth J Hughes; Karen Iloni; Maurice A Kibel; Stanley R Ress
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

Review 2.  The immunology of tuberculosis: from bench to bedside.

Authors:  Keertan Dheda; Stephan K Schwander; Bingdong Zhu; Richard N van Zyl-Smit; Ying Zhang
Journal:  Respirology       Date:  2010-04       Impact factor: 6.424

3.  Association of VDR gene polymorphisms and 22 bp deletions in the promoter region of TLR2Δ22 (-196-174) with increased risk of pulmonary tuberculosis: A case-control study in tea garden communities of Assam.

Authors:  Kangjam Rekha Devi; Kaustab Mukherjee; Pradipta Kumar Chelleng; Simanta Kalita; Upasana Das; Kanwar Narain
Journal:  J Clin Lab Anal       Date:  2018-05-04       Impact factor: 2.352

4.  Cytokine profiles of patients infected with Mycobacterium ulcerans and unaffected household contacts.

Authors:  Travis M Gooding; Paul D R Johnson; May Smith; Andrew S Kemp; Roy M Robins-Browne
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

5.  In mice, tuberculosis progression is associated with intensive inflammatory response and the accumulation of Gr-1 cells in the lungs.

Authors:  Irina V Lyadova; Evgeny N Tsiganov; Marina A Kapina; Galena S Shepelkova; Vasily V Sosunov; Tatiana V Radaeva; Konstantin B Majorov; Natalya S Shmitova; Henk-Jan van den Ham; Vitaly V Ganusov; Rob J De Boer; Rachael Racine; Gary M Winslow
Journal:  PLoS One       Date:  2010-05-04       Impact factor: 3.240

6.  Tuberculosis in household contacts of infectious cases in Kampala, Uganda.

Authors:  D Guwatudde; M Nakakeeto; E C Jones-Lopez; A Maganda; A Chiunda; R D Mugerwa; J J Ellner; G Bukenya; C C Whalen
Journal:  Am J Epidemiol       Date:  2003-11-01       Impact factor: 4.897

7.  Footprints of genetic susceptibility to pulmonary tuberculosis: cytokine gene variants in north Indians.

Authors:  Mridula Bose; Pankaj Jha
Journal:  Indian J Med Res       Date:  2012-05       Impact factor: 2.375

8.  Association between TNF-Alpha (-857) Gene Polymorphism and Susceptibility to Tuberculosis.

Authors:  S Anoosheh; P Farnia; M Kargar
Journal:  Iran Red Crescent Med J       Date:  2011-04-01       Impact factor: 0.611

9.  TLR1 Variant H305L Associated with Protection from Pulmonary Tuberculosis.

Authors:  Christian G Meyer; Norbert Reiling; Christa Ehmen; Gerd Ruge; Ellis Owusu-Dabo; Rolf D Horstmann; Thorsten Thye
Journal:  PLoS One       Date:  2016-05-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.